Young, Fully Vaccinated Australians, Dying By Mrs Vera West
This is one where the video presentation is must viewing. An Australian emergency room doctor details how the Covid vaccinated are dying like the proverbial flies, and the cases of myocarditis and pericarditis in the young has surged. According to the whistle-blower doctor’s experience as an emergency room doctor, a vast majority of these cases were caused by either Pfizer or Moderna’s Covid vaccine. In his opinion, the mRNA vaccines are still experimental, and the vaccinated population are the test subjects, or lab rats, all for the profits of Big pHARMa.
https://www.brighteon.com/2a8b23ab-5d0b-4e1e-aeb1-8d9bac15c8b1
“An emergency room doctor in Australia revealed that those who are fully vaccinated against the Wuhan coronavirus (COVID-19) are dying in droves.
The Australian doctor’s face and voice had to be obscured to protect his identity for fear of possible retaliation by Australian public health authorities and other government entities. “But I am blowing the whistle,” he proclaimed.
The doctor-turned-whistleblower first directed his concerns at the Australian government’s mass vaccination program including children.
“I am increasingly perplexed at the continued government backing of a medical intervention marred by serious complications in the young when there are zero benefits this treatment offers them.”
The whistleblower pointed out that the phase three drug trials for the COVID-19 vaccines for children between the ages of five and 11 were rushed and not extensive enough. It only featured around 600 subjects who were put through a six-month preliminary study wherein no adverse effects were reported.
According to the whistleblower, the trial claimed that there may always be serious complications with any medication “but these are unpredictable.”
But since the vaccine was approved for administration among those under 18-years-old, the number of cases of myocarditis and pericarditis in the young has surged. According to the whistleblower’s experience as an emergency room doctor, a vast majority of these cases were caused by either Pfizer or Moderna’s COVID-19 vaccine.
The whistleblower pointed out that myocarditis is “virtually unheard of” for people under the age of 40. Many of the myocarditis cases involving the vaccines that he saw led to other heart complications including shortness of breath, chest pains, heart attack and even acute heart failure.
“One can logically put two and two together and surmise that the vaccine had something to do with these serious complications,” he said.
“As much as Pfizer, Moderna and the media will have you believe this is rare, I have diagnosed these conditions in young men and women after getting the Pfizer and Moderna jabs, especially after the second dose,” said the whistleblower.
Australian government moving forward with plans to vaccinate younger children
Starting Jan. 10, 2022, the Australian government will allow all children aged five to 11 to receive Pfizer’s COVID-19 vaccine.
The Therapeutic Goods Administration, Australia’s main drug regulatory body, supposedly “made a careful, thorough assessment” and determined that Pfizer’s vaccine “is safe and effective and that it is in the interests of children and Australians for children five to11 to be vaccinated,” said Minister of Health Greg Hunt.
There are about 2.3 million children between the ages of five and 11 in Australia. Come Jan. 10, most of them will be subjected to these experimental and deadly vaccines.
“If we are risking this in our children, and I can tell you the risk, however small, is very significant with these vaccines that don’t prevent infection or transmission of COVID, they carry an inherent risk of permanent heart damage, while providing absolutely no benefit to the child nor anyone else,” said the whistleblower. “Why should we subject our children to these shots?”
The whistleblower appealed to Australian parents to think about their children before getting them vaccinated against COVID-19.
“Parents, you might think that the vaccine offers your child freedoms, even if you know it provides no health benefit to your son or daughter,” he said. “But what good would that school excursion be, if they suffer from a reduction in their heart function for the rest of their lives and will almost certainly shorten their lives if they do get vaccine complication?”
The whistleblower also sent a message to Australian doctors, saying that they should not be afraid to speak out.
“Being complicit with the unnecessary harm we are unintentionally causing when we knew better or were convinced of the hierarchical narrative does not absolve us of the ethical duty to protect our patients,” he said.
Finally, the whistleblower called out Australia’s politicians to think of the people who are being affected by these dangerous vaccines.
“These are real people they are permanently affecting, not just statistics,” he said. “Stop the mandates and discrimination based on medical status. It is unnecessarily harming people in more ways than one.””
Heart inflammation issues are a real concern, and here is a complementary US take on this issue:
“At least eight cases of myocarditis, or heart inflammation, in children 5 to 11 years old who got the Pfizer-BioNTech COVID vaccine were reported to the Centers for Disease Control and Prevention (CDC), the agency said during a Dec. 16 meeting.
The cases were reported in the Vaccine Adverse Event Reporting System (VAERS) and presented by a CDC official to a panel of its vaccine advisers.
The CDC acknowledged the reports on the same day Pfizer and BioNTech announced they had submitted a supplemental Biologics License Application to the U.S. Food and Drug Administration (FDA) to expand the approval of their Comirnaty vaccine — not yet available in the U.S. — to include individuals ages 12 through 15 years.
During the Dec. 16 meeting of the CDC’s vaccine advisory panel, the CDC said there had been more than 7 million vaccine doses administered in the 5 to 11 age group at the time the agency examined the data, including 5.1 million first doses and 2 million second doses.
The CDC said there had been 3,233 reports to VAERS of adverse events among 5- to 11-year-olds, including 14 reports of myocarditis, five reports with follow-up in progress, nine reports with follow-up information obtained and eight reports of myocarditis that met the CDC’s working case definition, including four males and five females.
Two cases occurred after the first dose and six cases occurred after the second dose. One report is under review.
Myocarditis is inflammation of the heart muscle that can lead to cardiac arrhythmia and death. According to the National Organization for Rare Disorders, myocarditis can result from infections, but “more commonly the myocarditis is a result of the body’s immune reaction to the initial heart damage.”
The CDC said cases were mild. But the agency did not confirm whether there was a link between myocarditis cases and the vaccine. It also did not disclose the rate of myocarditis among unvaccinated children in this age group.
The agency previously said reporting rates of myocarditis for boys 16 to 17 years old could be more than 69 cases per million following a second dose, and around 40 cases per million in boys 12 to 15 years old following a second dose.
Despite the potential for the vaccine to cause heart inflammation, the CDC continues to encourage all parents to get their children 5 years and older vaccinated against COVID, saying the long-term effects of the virus outweigh the side effects of the vaccine.
“The known risks of COVID-19 illness and its related, possibly severe complications, such as long-term health problems, hospitalization, and even death, far outweigh the potential risks of having a rare adverse reaction to vaccination, including the possible risk of myocarditis or pericarditis,” according to the CDC.
Commenting on the advisory panel’s meeting, pediatrician Dr. Liz Mumper told The Defender:
“I did not see that the committee looked at the basic issue of risk-benefit analysis underlying the validity of widespread vaccination in the pediatric population, given the extremely low mortality rate in this population and the potential long-term effects of myocarditis, clotting abnormalities and neurologic dysfunction in children.
“I did not see data presented on how children do not typically transmit COVID-19 to the vulnerable nor any ethical arguments about asking children to undertake long-term health risks on the unproven assumption of protecting the elderly and medically vulnerable.”
The CDC advised speaking to one’s healthcare provider or child’s pediatrician if any concerns arise.
Pfizer and BioNTech claim 100% protection against COVID for ages 12 to 15
Pfizer and BioNTech’s request last week to expand approval of the Comirnaty vaccine to include individuals 12- to 15-year-olds claims the shot gave 100% protection against the virus in the age group among those sampled.
The companies pointed to the results of their 2,228-person trial released in November, which found zero cases of COVID among fully vaccinated 12- to 15-year-olds when tested seven days to over four months after receiving a second dose of the Pfizer-BioNTech vaccine.
Pfizer said in a press release, the adverse event profile was “generally consistent with other clinical safety data for the vaccine, with a favorable safety profile observed in individuals with at least six months of safety follow-up after the second dose.”
Problems with Pfizer’s clinical trial in 12- to 15-year-olds
According to the Canadian COVID Care Alliance (CCCA) — a group of more than 500 independent Canadian doctors, scientists and healthcare practitioners committed to providing evidence-based information to the public about COVID, Pfizer’s original clinical trial of 12- to 15-year-old was too small to show risk and showed no benefit — only 1,005 participants were vaccinated and 978 received the placebo.
Pfizer boasted great results during the clinical trial, but the adolescents they tested were at a statistically 0% risk of death from COVID, so receiving the vaccine wouldn’t have benefited them in the first place, CCCA said.
What the vaccine did do was increase the risk of adverse events, which the clinical trial wasn’t designed to detect.
There was at least one very serious adverse event during the 12 to 15 clinical trial — Maddie de Garay, a 12-year-old girl from Ohio.
“Maddie developed gastroparesis, nausea and vomiting, erratic blood pressure, memory loss, brain fog, headaches, dizziness, fainting, seizures, verbal and motor tics, menstrual cycle issues, lost feeling from the waist down, lost bowel and bladder control and had a nasogastric tube placed because she lost her ability to eat,” CCCA said. “For the past 10 months, she has been in a wheelchair and fed via tube.”
In Pfizer’s report, de Garay’s adverse reaction was described as “functional abdominal pain.”
Pfizer continues to advertise its vaccine as safe and effective, but data is lacking and they even admit their clinical trial was too small to detect rare side effects, CCCA said.
Pfizer changed Pfizer-BioNTech vaccine formula
The FDA on Oct. 29 approved Emergency Use Authorization (EUA) of the Pfizer-BioNTech COVID vaccine for children 5 to 11 years old, while at the same time, signing off on a new formula — containing tromethamine (Tris) — without having completed animal or human clinical trials to assess safety or efficacy.
The FDA only reviewed Pfizer’s “analytical comparability assessments” to evaluate if Pfizer’s COVID vaccine formulations containing Tris and phosphate-buffered saline (PBS) buffers were “analytically comparable.”
Pfizer said the “change in buffer is not considered clinically significant,” and is used to simplify administration and increase storage times in pharmaceutical products.
The new formula is authorized for emergency use in individuals 5 to 11 and in those 12 years of age and older, according to the Pfizer-BioNTech EUA letter of authorization (LOA) reissued by the FDA on Oct. 29.
However, the Comirnaty vaccine was not subject to the formula change. The Pfizer-BioNTech vaccine can contain either the phos or tris buffer — which was not used in any of the clinical trials. The Comirnaty vaccine contains the PBS buffer.
Pfizer’s Comirnaty COVID vaccine was fully approved by the FDA for individuals ages 16 and older in August, although it is not yet available in the U.S. Pfizer’s Comirnaty is the only COVID vaccine that has received full FDA approval.
Full approval means the companies will be able to continue producing the vaccine after the COVID pandemic is over, and will be allowed to market the product, Forbes reported.
It also paves the way for a COVID vaccine to be mandated for the 12 to 15 age group, and affects whether the pharmaceutical company can be held liable for harms caused by its product.”
And here is one personal story of a most likely vaccine-caused death of a former healthy young man:
“Pfizer’s COVID vaccine “probably” caused the death of a healthy 26-year-old man, New Zealand health authorities said Monday.
The health officials attributed Rory James Nairn’s death, 12 days after his first COVID shot, to myocarditis.
“With the current available information, the board has considered that the myocarditis was probably due to vaccination in this individual,” a COVID-19 Vaccine Independent Safety Monitoring Board said in a statement.
Myocarditis is inflammation of the heart muscle that can lead to cardiac arrhythmia and death. It can also result from infections, but more commonly myocarditis is a result of the body’s immune reaction to initial heart damage.
Nairn’s death is New Zealand’s second reported death linked to myocarditis. Health authorities in August reported a woman died from heart inflammation likely due to the vaccine.
The board said:
“The circumstances of these cases do not impact or change the known information on myocarditis, and the benefits of vaccination with the Pfizer vaccine for COVID-19 continue to greatly outweigh the risk of such rare side effects.
“The Board has recommended actions to be taken by the COVID-19 Vaccine and Immunization Program to continue to highlight myocarditis as a very rare side effect of the Pfizer vaccine.”
A Pfizer spokesperson said the company was aware of the reported death in New Zealand, and that it monitors all reports of possible adverse events and continues to believe the benefit-risk profile for its vaccine is positive.
Nairn’s fiancée, Ashleigh Wilson, is searching for answers after the “traumatic” ordeal.
In a video interview with Chantelle Baker from B-2020, Wilson said her fiancé passed away from what paramedics believe was a heart attack.
Wilson said Nairn began experiencing heart palpitations on Nov. 5, the same day he received his first shot but that didn’t recognize the severity of his symptoms.
Wilson told the NZ Herald Nairn went into the bathroom as the two were preparing to leave for the hospital. That’s when she heard a thud.
“He had fallen, his body was blocking the door, his full weight was against it and I couldn’t get it open,” Wilson said. “I could just see him through a crack in the door, I could see that he was gone.”
“I watched him die and I could not get to him,” she said.
Wilson, who also got the vaccine, said the public should be more aware of the potential side effects so they know to seek help immediately. The risks in the small pamphlet handed out after people get the vaccine “are all a bit blasé,” she said.
A few days after Nairn died, Wilson said she looked at his phone and saw Google searches about myocarditis and “heart racing after the vaccine.”
“There were about 10 of them and they were all searched about an hour before he passed away, so I think that night he was starting to panic,” Wilson said. “He thought it was from the vaccine, and in his mind, he started experiencing those symptoms obviously after he had that vaccine.”
Wilson said she “110%” believes Nairn died from the vaccination. She encouraged young men to seek medical attention and not to downplay their symptoms.
New Zealand’s vaccine safety board said another two people, including a 13-year-old and a 60-year-old, died with possible myocarditis after receiving COVID vaccines.
More details are needed before linking the child’s death to the vaccine, but the 60-year-old man’s death was deemed “likely unrelated.”
Comments